[18F]-FDG

DRUG2 trials

Sponsors

University of Alabama at Birmingham, Affiliated Hospital of Jiangnan University

Conditions

Breast Cancer Stage IIBreast Cancer Stage IIIHER2-positive Breast CancerSolid Tumor

Early Phase 1

Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy

Affiliated Hospital of Jiangnan UniversityBreast Cancer Stage II, Breast Cancer Stage III, Solid Tumor

Start: 2023-01-31End: 2024-01-31Target: 10Updated: 2023-04-25

Phase 1

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

WithdrawnNCT04273555

University of Alabama at BirminghamHER2-positive Breast Cancer

Start: 2026-03-01End: 2028-06-30Updated: 2026-07-01